Chest
Volume 113, Issue 3, March 1998, Pages 768-773
Journal home page for Chest

Clinical Investigations in Critical Care
Transcutaneous Pco2 to Monitor Noninvasive Mechanical Ventilation in Adults: Assessment of a New Transcutaneous Pco2 Device

https://doi.org/10.1378/chest.113.3.768Get rights and content

The present study was designed to analyze the usability of a commercially available, transcutaneous Pco2 (TcPco2) sensor for monitoring noninvasive positive pressure ventilation (NPPV). Twenty-six hemodynamically stable patients with intra-arterial radial catheters were assessed. After stabilization of TcPco2, arterial blood was analyzed and results were compared with TcPco2 at time of sampling. To evaluate the drift of the signal, samples were taken hourly in five patients for 4 h while continuously recording TcPco2. Finally, to assess for the response of the sensor to changes in PaCO2, six patients underwent continuous TcPco2 recording while initiating or interrupting NPPV; arterial samples were analyzed before the event, and 1, 3, 5, 7, 9, and 20 min afterwards.

Results

TcPco2 and PaCO2 were tested over a range of 26 to 71 mm Hg, and were found to be closely correlated (r=0.968, p<0.0001); mean bias was 0.75 mm Hg. There was no significant drift of TcPco2 as compared with PaCO2 over 4 h. The time of response of TcPco2 to initiation or interruption of NPPV was <60 s. An estimation of the lag time averaged 5±3 min (range, 1 to 9 min).

Conclusion

TcPco2 in hemodynamically stable adults was in excellent agreement with arterial measurements. The time of response to a change in ventilation was compatible with the aim of clinical monitoring of patients under NPPV.

Section snippets

Materials and Methods

The study protocol was approved by the Ethics Committee of the University Hospital of Geneva. Patients who had been admitted in the ICU and equipped with an indwelling arterial catheter were considered for the present study. To be included, they had to be in hemodynamically stable condition without vasopressor amine treatment other than low-dose dopamine (≤0.2 mg/min) to avoid cutaneous hypoperfusion or vasoconstriction. Twenty-six patients were included (18 men, 8 women, aged 68±10 years).

Results

Agreement between transcutaneous and arterial values for CO2 was tested over a range of 26 to 71 mm Hg. TcPco2 as a function of PaCO2 is shown on Figure 2. Both measurements were highly correlated (r=0.968, p<0.001), and linear regression was close to the identity line (TcPco2=1.116×PaCO2—0.46). Figure 2 indicates that at high Pco2 values, there was a trend for TcPco2 to slightly overestimate PaCO2. Figure 3 shows the d and limits of agreement between the TcPco2 and PaCO2. The d was 0.75 mm Hg;

Discussion

We have shown that TcPco2 values, measured with the capnograph (Fastrac), showed a good agreement with simultaneous arterial measurements of PaCO2, without significant drift after 4 h of continuous recording.

A review of published studies, as summarized in Table 1, shows conflicting results regarding agreement between TcPco2 and PaCO2.3,7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17 Five studies, however, gave excellent correlation, two of them7, 11 indicating Pearson's coefficient of correlation (r)

References (27)

  • SeveringhausJW et al.

    TcPco2 electrode design, calibration and temperature gradient problems

    Acta Anaesthesiol Scand

    (1978)
  • PilsburyD et al.

    An ambulatory system for long-term continuous monitoring of transcutaneous Pco2

    Bull Eur Physiopathol Respir

    (1987)
  • MahutteK et al.

    Evaluation of a single transcutaneous Po2-Pco2 sensor in adult patients

    Crit Care Med

    (1984)
  • Cited by (100)

    View all citing articles on Scopus
    View full text